Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZM stock price vs ELV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ELV's multiple
Needs ELV P/E.
Implied fair value · at ZM's multiple
Needs ZM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZM FY 2026 (ended Jan 31, 2026) · ELV FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 5.87x · EV / EBITDA 11.08x
Capital structure 73% equity / 27% debt · EV / Revenue 0.56x · EV / EBITDA 13.58x
ELV carries the larger enterprise value at $111.88B against $28.59B; ELV trades on the lower EV / Revenue multiple (0.56x vs 5.87x); ZM on the lower EV / EBITDA (11.08x vs 13.58x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zoom Communications, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ELEVANCE HEALTH, INC. · implied price per share
Bear
$190.58
Base
$247.47
Bull
$324.22
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.01x
0.75x
Net debt / EBITDA
Leverage against operating earnings
-0.45x
2.85x
Cash and equivalents
Liquid reserves on the balance sheet
$1.27B
$9.49B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$107.04M
$33.00B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ZM can sustain its 23.1% operating margin while re-accelerating growth above 4.4%, then holding or accumulating makes sense because the current price is only modestly above the P/E-implied value and ZM already has strong profitability and low leverage.
ZM's current price of $98.25 is 4.5% above the P/E-based implied price of $93.83, suggesting only a small valuation premium. That premium is tempered by the fact that ZM also sits within its historical band and well above the DCF range, so the stock does not look deeply cheap on this data set.
Supporting Metrics
